C9H11NS2, monoclinic, P21/n (no. 14), a = 5.6183(1) Å, b = 18.2426(3) Å, c = 9.5185(2) Å, β = 96.835(2)°, V = 968.64(3) Å3, Z = 4, Rgt(F) = 0.0303, wRref(F2) = 0.0826, T = 100(2) K
C12H17NO2S2, monoclinic, P1211 (No. 4), a = 8.953(9) Å, b = 16.135(8) Å, c = 9.049(4) Å, β = 104.90(...
C16H21NO2S, monoclinic, C121(No. 5), a = 19.844(5) Angstrom, b = 5.684(2) Angstrom, c = 14.646(6) An...
C9H13N3O2S, monoclinic, P21/c (no. 14), a = 8.0984(4) Å, b = 17.3203(10) Å, c = 9.6802(4) Å, β = 124...
C11H15NOS, monoclinic, P21/n (no. 14), a = 7.3979(4) Å, b = 8.5384(4) Å, c = 18.2771(10) Å, β = 90.9...
C11H15NOS, monoclinic, C2/c (no. 15), a = 21.0452(12) Å, b = 6.1447(4) Å, c = 17.1892(10) Å, β = 93....
There are two molecules in the asymmetric unit of the title compound, C9H10N2OS. In one, the dihedra...
The title compound, C9H10O2S, (I), crystallizes in the triclinic space group, P − 1, with unit cell ...
C14H12ClN3S, monoclinic, C2/c (no. 15), a = 27.967(7) Å, b = 5.9290(13) Å, c = 19.698(5) Å, β = 118....
[C21H28N4S2], monoclinic, P21/c (no. 14), a = 16.1880(2) Å, b = 6.8168(1) Å, c = 19.7605(2) Å, β = 1...
The title compounds, (N-methyl-N-phenylamino)(N-methyl-N-phenylcarbamoyl)sulfide, C15H16N2OS, (I), a...
The title compound, C9H10O2S, (I), crystallizes in the triclinic space group, P − 1, with unit cell ...
In the crystal structure of the title compound, C11H14N2OS, the six atoms of the central C2N2OS resi...
The title compound, C9H11N3S2, crystallizes with two molecules in the asymmetric unit, which differ...
Crystal structures of two N-(aryl)arylsulfonamides, namely, 4-methoxy-N-(4-methylphenyl)benzenesulfo...
There are two independent molecules in the asymmetric unit of the title compound, C6H12N2S, in which...
C12H17NO2S2, monoclinic, P1211 (No. 4), a = 8.953(9) Å, b = 16.135(8) Å, c = 9.049(4) Å, β = 104.90(...
C16H21NO2S, monoclinic, C121(No. 5), a = 19.844(5) Angstrom, b = 5.684(2) Angstrom, c = 14.646(6) An...
C9H13N3O2S, monoclinic, P21/c (no. 14), a = 8.0984(4) Å, b = 17.3203(10) Å, c = 9.6802(4) Å, β = 124...
C11H15NOS, monoclinic, P21/n (no. 14), a = 7.3979(4) Å, b = 8.5384(4) Å, c = 18.2771(10) Å, β = 90.9...
C11H15NOS, monoclinic, C2/c (no. 15), a = 21.0452(12) Å, b = 6.1447(4) Å, c = 17.1892(10) Å, β = 93....
There are two molecules in the asymmetric unit of the title compound, C9H10N2OS. In one, the dihedra...
The title compound, C9H10O2S, (I), crystallizes in the triclinic space group, P − 1, with unit cell ...
C14H12ClN3S, monoclinic, C2/c (no. 15), a = 27.967(7) Å, b = 5.9290(13) Å, c = 19.698(5) Å, β = 118....
[C21H28N4S2], monoclinic, P21/c (no. 14), a = 16.1880(2) Å, b = 6.8168(1) Å, c = 19.7605(2) Å, β = 1...
The title compounds, (N-methyl-N-phenylamino)(N-methyl-N-phenylcarbamoyl)sulfide, C15H16N2OS, (I), a...
The title compound, C9H10O2S, (I), crystallizes in the triclinic space group, P − 1, with unit cell ...
In the crystal structure of the title compound, C11H14N2OS, the six atoms of the central C2N2OS resi...
The title compound, C9H11N3S2, crystallizes with two molecules in the asymmetric unit, which differ...
Crystal structures of two N-(aryl)arylsulfonamides, namely, 4-methoxy-N-(4-methylphenyl)benzenesulfo...
There are two independent molecules in the asymmetric unit of the title compound, C6H12N2S, in which...
C12H17NO2S2, monoclinic, P1211 (No. 4), a = 8.953(9) Å, b = 16.135(8) Å, c = 9.049(4) Å, β = 104.90(...
C16H21NO2S, monoclinic, C121(No. 5), a = 19.844(5) Angstrom, b = 5.684(2) Angstrom, c = 14.646(6) An...
C9H13N3O2S, monoclinic, P21/c (no. 14), a = 8.0984(4) Å, b = 17.3203(10) Å, c = 9.6802(4) Å, β = 124...
DOI
Add to ORKG